State of New Jersey Common Pension Fund D Trims Stake in Prestige Consumer Healthcare Inc. $PBH

State of New Jersey Common Pension Fund D lessened its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 48.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 16,798 shares of the company’s stock after selling 15,701 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Prestige Consumer Healthcare were worth $1,036,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the company. Profund Advisors LLC raised its position in Prestige Consumer Healthcare by 3.2% in the 3rd quarter. Profund Advisors LLC now owns 6,770 shares of the company’s stock worth $422,000 after purchasing an additional 207 shares during the period. Cerity Partners LLC boosted its position in shares of Prestige Consumer Healthcare by 5.9% during the second quarter. Cerity Partners LLC now owns 3,884 shares of the company’s stock valued at $310,000 after buying an additional 218 shares during the period. Diversify Advisory Services LLC boosted its position in shares of Prestige Consumer Healthcare by 4.6% during the third quarter. Diversify Advisory Services LLC now owns 5,837 shares of the company’s stock valued at $354,000 after buying an additional 256 shares during the period. Geneos Wealth Management Inc. grew its stake in shares of Prestige Consumer Healthcare by 92.8% during the first quarter. Geneos Wealth Management Inc. now owns 559 shares of the company’s stock valued at $48,000 after buying an additional 269 shares during the last quarter. Finally, Barrow Hanley Mewhinney & Strauss LLC grew its stake in shares of Prestige Consumer Healthcare by 106.8% during the third quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 548 shares of the company’s stock valued at $34,000 after buying an additional 283 shares during the last quarter. 99.95% of the stock is currently owned by institutional investors.

Insider Activity

In related news, VP Jeffrey Zerillo sold 1,207 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The stock was sold at an average price of $54.99, for a total value of $66,372.93. Following the completion of the sale, the vice president owned 42,820 shares in the company, valued at approximately $2,354,671.80. The trade was a 2.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold a total of 2,553 shares of company stock valued at $151,444 in the last ninety days. 1.40% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

PBH has been the subject of a number of research analyst reports. Jefferies Financial Group decreased their price target on Prestige Consumer Healthcare from $70.00 to $66.00 and set a “hold” rating for the company in a research note on Friday, January 30th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Prestige Consumer Healthcare in a research report on Tuesday, April 21st. Finally, Oppenheimer decreased their target price on Prestige Consumer Healthcare from $77.00 to $65.00 and set an “outperform” rating for the company in a research report on Thursday, May 7th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Prestige Consumer Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $74.75.

Prestige Consumer Healthcare Price Performance

Prestige Consumer Healthcare stock opened at $50.53 on Tuesday. The company has a debt-to-equity ratio of 0.58, a current ratio of 3.11 and a quick ratio of 1.93. The stock has a market cap of $2.39 billion, a price-to-earnings ratio of 13.37, a price-to-earnings-growth ratio of 1.57 and a beta of 0.40. The firm has a 50-day moving average of $59.50 and a two-hundred day moving average of $61.77. Prestige Consumer Healthcare Inc. has a 1 year low of $49.28 and a 1 year high of $89.37.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare, Inc is a leading manufacturer and marketer of branded over-the-counter (OTC) healthcare products. The company focuses on developing, acquiring and commercializing a diverse portfolio of non-prescription remedies designed to address common consumer health needs, including pain relief, cold and cough, digestive health, eye care, skin care and women’s health.

Key brands in Prestige’s portfolio include Clear Eyes (eye health), Carmex (lip care), Chloraseptic (sore throat relief), Dramamine (motion sickness), Rolaids (antacid), Monistat (women’s health), BC Powder (pain relief), Little Remedies (pediatric cold and gas relief) and TheraTears (dry eye therapy).